Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVCA: Foam Sclerotherapy vs. Catheter Directed Foam vs. ClariVein for Varicose Veins
NCT02010437Phase 4Withdrawn
- Sponsor
- Hull University Teaching Hospitals
- Start
- Jan 2014
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sodium tetradecyl sulfate in superficial venous insufficiency (SVI), sponsored by Hull University Teaching Hospitals. Primary endpoint: Technical success rate of treatment at 1 year. Planned start Jan 2014; status: withdrawn.
02
Drugs
sodium tetradecyl sulfate
03
Conditions
superficial venous insufficiency (SVI)
Beyond the preview
Go deeper on NCT02010437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02010437.